Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Endo USA, Inc. recalls Everolimus tablets 5mg

Class IIIofficial

FDA Class III

FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).

Hazard
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Products
  • Everolimus tablets 5mg
Where it was sold

Nationwide within the United States

Nationwide

Units affected
6,655 cartons
About this recall
Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-125-91